Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Cybersecurity Allegations, Safety Alert Will Not Impact St. Jude Acquisition, Abbott Affirms

Executive Summary

Abbott Labs' CEO Miles White expressed strong confidence in St. Jude and an unimpeded acquisition of the firm in the wake of continued cybersecurity allegations and a device-safety advisory.

Advertisement

Related Content

Earnings Winners And Losers: ABT, ISRG, JNJ, STJ
No Surprise As Abbott Cuts Loose Angio-Seal, Femoseal To Terumo
St. Jude Warns Of Battery-Depletion Issues With Some ICDs
St. Jude Hacking-Risk Allegations: US FDA Continues Assessment, As Firm Files Lawsuit
The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register